New: the 2026 Denial & Margin Benchmark is in progress, targeting a Q1 2027 release — free when it publishes.
Get the benchmark →
Demonstrated results
Across three decades in the revenue cycle, on both the provider and payer sides of the table.
$1.2M+
OB/GYN multi-site network
Recovered in previously lost revenue.
25%
Behavioral health group
Reduction in denials through an evidence-led approach.
39 days
Maternal-fetal medicine practice
Cut from A/R, releasing $1.8M in cash flow.
~$500M
Hospital & professional billing
Reconciled across accounts receivable.
These are anonymized prior engagement outcomes shown to illustrate the type of measurable financial and operational impact Emphanex has supported; client-identifying details are omitted for confidentiality. Past results are not a guarantee of future outcomes. See our Terms for details.
Access our research
Rigorous analysis for finance leaders, plus the annual benchmark on release.
Read Insights →Request the Data Diagnostic
Free, scoped to your data, your remittance data under a BAA.
See how it works →Speak with our team
Fifteen to thirty minutes — enrollment questions welcome. No preparation required.
Start your inquiry →